The Drugreporter Podcast10 Dec 2024

The EHRC 2024 Sessions: 4. Medication assisted therapies in EECA: status and progress | 6th European Harm Reduction Conference, Warsaw, 2024

The session provides an overview of the status and progress made in the EECA region to respond to the changing drug scene with medication assisted treatments that have developed in the last several years.
The session will provide an overview of the drug scene in EECA and its most recent changes.
It will highlight the case of Ukraine that managed to deliver life-saving OAT during the war and even more – introduce the innovation of providing long-acting depot buprenorphine (LADB) and expand OAT in prison settings.
The case of Kyrgyzstan introducing LADB for people who inject opioids within a pilot study to assess the feasibility as part of a UNITAID project will be presented.
Experience of providing ADHD medication to stimulant users within SoS project 2.0 will be shared in the context of Czech program on stimulant users medically-assisted treatment. The Czech Republic have been implementing methylphenidate based MAT to stimulant drug users for over 7 years in several settings - clinical and NGO drop-in centers. Ukraine has launched a pilot in 4 cities on the basis of narcological clinics that will allow to assess how the program helps stimulant users with ADHD cope with usage by means of treating ADHD medically, as well as providing psychosocial support aimed at reducing use, as well as the influence on the quality of life and the acceptability of the service in general.
Partners from Slovenia and Romania will share their experience of interesting approaches and developments in OAT provision, such as utilising mobile units and NGOs, a variety of medication options available and reaching solid coverage.
The session will also include representatives of the PWUD community; sharing their personal and community experience in relation to monitoring access and quality of medications, based on their recent experience of ECAT on OST.
Moderator: Maria Malakhova
Subsessions
Which factors facilitate or hinder the implementation of injectable opioid agonist treatment? A scoping review
December 02, 2024 4:00 PM – 4:10 PM
Fragile Grassroots Solidarities. On the Situation of Opioid Users in Poland.
December 02, 2024 4:10 PM – 4:20 PM
Introducing Long-Acting Depot Buprenorphine in Kyrgyzstan: A Feasibility Study
December 02, 2024 4:20 PM – 4:30 PM

Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(116)

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Maj 16min

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therap...

20 Apr 30min

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh

With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovb...

17 Apr 26min

Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and Is...

10 Apr 57min

Every step to improve lives is worth fighting for — Martin Jelsma on a 30-year drug policy struggle

The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Trans...

31 Mars 37min

UNGASS Promises Unfulfilled: Marie Nougier on the Challenges Facing Global Drug Policy

Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug polic...

27 Mars 16min

“I’m incredibly proud of what we built” — Ann Fordham on Leaving IDPC After 17 Years

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global...

25 Mars 20min

Sabba: Building the Future of Psychedelic Therapy Education” — Interview with Jeremy Rudy

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.Jeremy Rudy is the founder and CEO of th...

23 Mars 20min